Arcturus Therapeutics Holdings Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ARCT Nasdaq 2836 arcturusrx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics launches Phase I Avian Influenza trials in US - Jan 10th, 2025 4:14 pm
Arcturus Therapeutics Announces Initiation of Phase 1 H5N1 Flu Vaccine Trial - Jan 10th, 2025 1:00 pm
Arcturus Therapeutics Announces Initiation of Dosing in Phase 2 Multiple Ascending Dose Studies for Cystic Fibrosis (CF) and Ornithine Transcarbamylase (OTC) Deficiency - Jan 6th, 2025 9:01 pm
High Growth Tech Stocks Including Arcturus Therapeutics Holdings And Two Others - Dec 24th, 2024 6:02 pm
We're Not Very Worried About Arcturus Therapeutics Holdings' (NASDAQ:ARCT) Cash Burn Rate - Dec 20th, 2024 11:34 am
Arcturus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference - Dec 16th, 2024 9:01 pm
Why Arcturus Therapeutics (ARCT) Is the Worst ARK Stock to Buy According to Short Sellers - Dec 11th, 2024 4:55 pm
Arcturus Therapeutics to Attend Upcoming Investor Conferences - Nov 26th, 2024 9:01 pm
Arcturus Therapeutics to Present at Jefferies London Healthcare Conference - Nov 19th, 2024 1:00 am
Meiji Seika Pharma Announces Investment in ARCALIS, Inc. - Nov 14th, 2024 6:00 am
Arcturus Therapeutics Receives Clearance from FDA to Begin H5N1 Pandemic Flu Vaccine Clinical Trial - Nov 11th, 2024 9:01 pm
Arcturus Therapeutics Holdings Third Quarter 2024 Earnings: Beats Expectations - Nov 9th, 2024 2:25 pm
Q3 2024 Arcturus Therapeutics Holdings Inc Earnings Call - Nov 8th, 2024 5:15 pm
Arcturus Therapeutics Holdings Inc (ARCT) Q3 2024 Earnings Call Highlights: Strategic Advances ... - Nov 8th, 2024 7:29 am
Arcturus Therapeutics (ARCT) Reports Q3 Loss, Lags Revenue Estimates - Nov 7th, 2024 10:55 pm
Arcturus Therapeutics: Q3 Earnings Snapshot - Nov 7th, 2024 9:48 pm
Arcturus Therapeutics Announces Third Quarter 2024 Financial Update and Pipeline Progress - Nov 7th, 2024 9:01 pm
Arcturus Gears Up to Report Q3 Earnings: Here's What to Expect - Nov 4th, 2024 3:05 pm
Arcturus Therapeutics to Report Third Quarter Financial Results and Provide Corporate Update on November 7, 2024 - Oct 31st, 2024 8:01 pm
Arcturus Therapeutics (ARCT) Upgraded to Buy: What Does It Mean for the Stock? - Oct 30th, 2024 4:00 pm